Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 29
Filter
1.
Rev Esp Quimioter ; 33(6): 466-484, 2020 Dec.
Article in English | MEDLINE | ID: mdl-33070578

ABSTRACT

The high transmissibility of SARS-CoV-2 before and shortly after the onset of symptoms suggests that only diagnosing and isolating symptomatic patients may not be sufficient to interrupt the spread of infection; therefore, public health measures such as personal distancing are also necessary. Additionally, it will be important to detect the newly infected individuals who remain asymptomatic, which may account for 50% or more of the cases. Molecular techniques are the "gold standard" for the diagnosis of SARS-CoV-2 infection. However, the massive use of these techniques has generated some problems. On the one hand, the scarcity of resources (analyzers, fungibles and reagents), and on the other the delay in the notification of results. These two facts translate into a lag in the application of isolation measures among cases and contacts, which favors the spread of the infection. Antigen detection tests are also direct diagnostic methods, with the advantage of obtaining the result in a few minutes and at the very "pointof-care". Furthermore, the simplicity and low cost of these tests allow them to be repeated on successive days in certain clinical settings. The sensitivity of antigen tests is generally lower than that of nucleic acid tests, although their specificity is comparable. Antigenic tests have been shown to be more valid in the days around the onset of symptoms, when the viral load in the nasopharynx is higher. Having a rapid and real-time viral detection assay such as the antigen test has been shown to be more useful to control the spread of the infection than more sensitive tests, but with greater cost and response time, such as in case of molecular tests. The main health institutions such as the WHO, the CDC and the Ministry of Health of the Government of Spain propose the use of antigenic tests in a wide variety of strategies to respond to the pandemic. This document aims to support physicians involved in the care of patients with suspected SC2 infection, in the context of a growing incidence in Spain since September 2020, which already represents the second pandemic wave of COVID-19.


Subject(s)
Antigens, Viral/blood , COVID-19 Serological Testing/methods , COVID-19/diagnosis , Consensus , Pandemics , SARS-CoV-2/immunology , Acute Disease , Adolescent , Adult , Age Distribution , Aged , Aged, 80 and over , Algorithms , COVID-19/epidemiology , COVID-19/mortality , COVID-19/transmission , COVID-19 Nucleic Acid Testing/standards , COVID-19 Serological Testing/standards , Child , Child, Preschool , Contact Tracing , Emergencies , Female , Humans , Incidence , Infant , Male , Middle Aged , Nasopharynx/virology , Sensitivity and Specificity , Spain/epidemiology , Specimen Handling/methods , Specimen Handling/standards , Young Adult
4.
Neurologia ; 29(9): 567-72, 2014.
Article in English, Spanish | MEDLINE | ID: mdl-24140159

ABSTRACT

INTRODUCTION: Epidemiological studies have demonstrated that patients with diabetes mellitus have an increased risk of developing Alzheimer disease, but the relationship between the 2 entities is not clear. DEVELOPMENT: Both diseases exhibit similar metabolic abnormalities: disordered glucose metabolism, abnormal insulin receptor signalling and insulin resistance, oxidative stress, and structural abnormalities in proteins and ß-amyloid deposits. Different hypotheses have emerged from experimental work in the last two decades. One of the most comprehensive relates the microvascular damage in diabetic polyneuritis with the central nervous system changes occurring in Alzheimer disease. Another hypothesis considers that cognitive impairment in both diabetes and Alzheimer disease is linked to a state of systemic oxidative stress. Recently, attenuation of cognitive impairment and normalisation of values in biochemical markers for oxidative stress were found in patients with Alzheimer disease and concomitant diabetes. Antidiabetic drugs may have a beneficial effect on glycolysis and its end products, and on other metabolic alterations. CONCLUSIONS: Diabetic patients are at increased risk for developing Alzheimer disease, but paradoxically, their biochemical alterations and cognitive impairment are less pronounced than in groups of dementia patients without diabetes. A deeper understanding of interactions between the pathogenic processes of both entities may lead to new therapeutic strategies that would slow or halt the progression of impairment.


Subject(s)
Alzheimer Disease/etiology , Diabetes Mellitus, Type 2/complications , Cognition Disorders/etiology , Dementia/etiology , Diabetes Mellitus, Type 2/metabolism , Disease Progression , Humans , Oxidative Stress
5.
Food Sci Technol Int ; 18(3): 207-17, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22701054

ABSTRACT

The objective of this work was to study the effect of partial sodium replacement by potassium and packaging conditions on the physicochemical properties of smoked sea bass during cold storage. Sea bass fillets were salted with 100% NaCl (Na samples) or with 50% NaCl-50% KCl (Na:K samples), smoked, packaged under three different conditions (air, vacuum and modified atmosphere) and stored at 4 °C for 42 days. Physicochemical parameters, color and texture were periodically determined in the raw material and in smoked samples during cold storage. The smoking process led to a reduction in moisture, pH and a(w) values, and an increase in water holding capacity, ash and mineral contents. Smoked fish exhibited significant differences in color and texture as compared to fresh fish. The type of packaging had an effect on the pH, water holding capacity and texture. Samples in air exhibited the highest pH values and water holding capacity in these samples gradually decreased during storage. Textural parameters decreased during storage in samples packaged in vacuum and modified atmosphere. The pH of Na samples was initially higher than in Na:K samples, and this difference remained over the rest of the study. The type of salt did not affect the texture or other physicochemical parameters.


Subject(s)
Food Preservation/methods , Food Storage , Meat/analysis , Sodium/chemistry , Animals , Bass , Time Factors
6.
J Neural Transm (Vienna) ; 115(1): 77-84, 2008.
Article in English | MEDLINE | ID: mdl-17726571

ABSTRACT

Increased concentrations of insulin, glucose and glycohemoglobin are associated with Type II diabetes mellitus (DM) and recognized as characteristic markers of the disease; in Alzheimer's (AD), Vascular dementia (VaD), and both dementia's with superimposed diabetes (AD + DM, VaD + DM) the knowledge is scarce. The sample (n = 122; males = 60; mean age = 73 +/- 7) comprised DM, AD, VaD, AD + DM, and VaD + DM patients, and healthy controls (C). The ANOVA's yielded significant differences between groups: Insulin p = 3.7 x 10(-3); Glucose p < 10(-12); Glycohemoglobin p = 9.2x10(-4). Comparisons between groups (DM vs. C, AD + DM vs. AD, VaD + DM vs. VaD, and demented DM vs. non-demented DM) resulted significant for all variables (Bonferroni's statistic, alpha = 0.05). Diabetic and diabetic demented patients presented significant increases largely different from controls (0.01 < p < 0.001), unlike the non-significant changes in their non-diabetic counterparts; linear relationships were found across all groups. The correlation's insulin/glucose and insulin/glycohemoglobin change to positive within demented groups, indicating a different performance of insulin in demented and non-demented subjects.


Subject(s)
Alzheimer Disease/blood , Blood Glucose/analysis , Dementia, Vascular/blood , Diabetes Mellitus, Type 2/blood , Glycated Hemoglobin/analysis , Insulin/blood , Aged , Alzheimer Disease/complications , Alzheimer Disease/pathology , Brain/pathology , Dementia, Vascular/complications , Dementia, Vascular/pathology , Diabetes Mellitus, Type 2/complications , Diabetes Mellitus, Type 2/pathology , Female , Humans , Magnetic Resonance Imaging , Male
7.
Int J Food Microbiol ; 116(1): 64-72, 2007 May 01.
Article in English | MEDLINE | ID: mdl-17303277

ABSTRACT

Water blanching and the use of additives (potassium sorbate and citric acid) combined with different types of packaging (air, vacuum "VP" and modified atmosphere packaging "MAP": 60% CO(2), 30% N(2) and 10% O(2)), were studied as new methods of preservation of chilled desalted cod. Microbial counts and total volatile basic nitrogen (TVB-N) analyses were carried out during a period of 42 days on all samples stored at 4 degrees C. No Aeromonas or sulphite-reducing Clostridium were isolated from any of the analysed samples. The lowest microbial counts of mesophilic, psychrotrophic, Pseudomonas, moulds and yeasts, were found in samples with additives in all kinds of packaging. These samples in VP or MAP maintained an excellent microbial quality throughout the 42 days of storage, with mesophilic and psychrotrophic counts always below 4 log CFU/g. Counts of the four microorganisms above-mentioned in blanched samples packaged with air, exceeded 5 log CFU/g on days 21-28, so it became necessary to use VP or MAP to maintain these microorganisms at an acceptable level for the entire storage period. TVB-N contents were low in samples with additives, regardless of the kind of packaging, as well as in blanched samples packaged in VP and MAP, never reaching 25 mg/100 g. Since there were no significant differences either in microbial growth or in TVB-N between samples in VP and MAP, a sensory analysis was performed only in desalted cod submitted to the two treatments (blanching and additives) combined with VP, both in raw and cooked samples. The results of this analysis showed that the addition of potassium sorbate and citric acid did not alter the typical organoleptic features of desalted cod. The sensory characteristics of both blanched samples and those with additives in VP showed no change during the period of the study.


Subject(s)
Food Packaging/methods , Food Preservation/methods , Food Preservatives/pharmacology , Gadus morhua/microbiology , Seafood/microbiology , Animals , Colony Count, Microbial , Consumer Product Safety , Food Contamination/prevention & control , Food Microbiology , Humans , Nitrogen/analysis , Taste , Temperature , Time Factors , Vacuum
8.
Rehabilitación (Madr., Ed. impr.) ; 40(3): 123-131, mayo 2006. tab, graf
Article in Es | IBECS | ID: ibc-046490

ABSTRACT

Introducción. La finalidad de este trabajo ha sido comparar los resultados de dos Unidades con distinto enfoque en la rehabilitación de la fractura de cadera. Pacientes y métodos. Estudio prospectivo de 286 pacientes mayores de 65 años, intervenidos de fractura de cadera durante los años 1997-2001; 143 realizaron la rehabilitación en una Unidad de Rehabilitación Geriátrica y otros 143 en una Unidad de Traumatología. Se analizaron datos sociodemográficos, situación funcional previa, comorbilidad, tipo de fractura y cirugía, tiempo de ingreso y de rehabilitación, complicaciones y mortalidad. Se compararon la capacidad de marcha (escala FAC) y la independencia en las actividades básicas de la vida diaria (índice de Katz) al alta, a los 3, 6 y 12 meses de la fractura de cadera entre ambos grupos. Se analizaron qué factores se asociaban con recuperación de la independencia mediante un análisis de regresión logística múltiple. Resultados. La recuperación de la independencia en la marcha y actividades básicas de la vida diaria fue mayor en los pacientes del grupo de Rehabilitación Geriátrica al alta (p < 0,001) y a los 3 meses sólo en la marcha (p < 0,05), pero no al 6.º y 12.º mes de la fractura de cadera. La edad menor y la ausencia de demencia fueron los factores que se asociaron con la recuperación de la independencia en las cuatro valoraciones (p < 0,05). Conclusiones. La atención de las fracturas de cadera en Unidades de Rehabilitación Geriátrica mejora los resultados funcionales durante los primeros meses, pero se igualan a partir del 6.º mes


Introduction. This study aims to compare the results of two Units with different approach in Rehabilitation of the hip fracture. Material and methods. Prospective study of 286 patients over 65 years, operated on for hip fracture during the years 1997-2001; 143 had rehabilitation in the Geriatric Rehabilitation Unit and 143 more in a Traumatology Unit. Sociodemographic data, previous functional situation, comorbidity, type of fracture and surgery, admission time and rehabilitation time, complications and mortality were analyzed. Gait capacity (FAC Scale) and independence in basic activities of daily life (Katz Index) were compared on discharge, at 3, 6, and 12 months of the hip fracture between both groups. Which factors were associated with recovery of independence were analyzed by a multiple logistic regression analysis. Results. Recovery of independence for gait and basic daily life activities was greater in patients from the Geriatric Rehabilitation group on discharge (p < 0.001) and at 3 months only in the gait (p < 0.05), but not at the 6th and 12th month of the hip fracture. Younger age and absence of dementia were the factors that were associated with recovery of independence in the four evaluations (p < 0.05). Conclusions. Care given to hip fractures in the Geriatric Rehabilitation Units improves the functional results during the first months, but this becomes equal after the 6th month


Subject(s)
Male , Female , Aged , Humans , Hip Fractures/rehabilitation , Rehabilitation Centers/statistics & numerical data , Prospective Studies , Recovery of Function , Quality Indicators, Health Care/statistics & numerical data
9.
Neurology ; 63(12): 2348-53, 2004 Dec 28.
Article in English | MEDLINE | ID: mdl-15623698

ABSTRACT

OBJECTIVE: To evaluate the efficacy of a cognitive-motor program in patients with early Alzheimer disease (AD) who are treated with a cholinesterase inhibitor (ChEI). METHODS: Patients with mild cognitive impairment (MCI) (12), mild AD (48), and moderate AD (24) (Global Deterioration Scale stages 3, 4, and 5) were randomized to receive psychosocial support plus cognitive-motor intervention (experimental group) or psychosocial support alone (control group). Cognitive-motor intervention (CMI) consisted of a 1-year structured program of 103 sessions of cognitive exercises, plus social and psychomotor activities. The primary efficacy measure was the cognitive subscale of the AD Assessment Scale (ADAS-cog). Secondary efficacy measures were the Mini-Mental State Examination, the Functional Activities Questionnaire, and the Geriatric Depression Scale. Evaluations were conducted at 1, 3, 6, and 12 months by blinded evaluators. RESULTS: Patients in the CMI group maintained cognitive status at month 6, whereas patients in the control group had significantly declined at that time. Cognitive response was higher in the patients with fewer years of formal education. In addition, more patients in the experimental group maintained or improved their affective status at month 12 (experimental group, 75%; control group, 47%; p = 0.017). CONCLUSIONS: A long-term CMI in ChEI-treated early Alzheimer disease patients produced additional mood and cognitive benefits.


Subject(s)
Alzheimer Disease/therapy , Cognition Disorders/therapy , Cognitive Behavioral Therapy , Physical Therapy Modalities , Aged , Aged, 80 and over , Alzheimer Disease/drug therapy , Caregivers/psychology , Cholinesterase Inhibitors/therapeutic use , Cognition Disorders/drug therapy , Combined Modality Therapy , Donepezil , Female , Follow-Up Studies , Humans , Indans/therapeutic use , Male , Middle Aged , Patient Satisfaction , Patients/psychology , Phenylcarbamates/therapeutic use , Piperidines/therapeutic use , Psychomotor Disorders/therapy , Rivastigmine , Single-Blind Method , Treatment Outcome
11.
An Med Interna ; 19(8): 389-95, 2002 Aug.
Article in Spanish | MEDLINE | ID: mdl-12244785

ABSTRACT

BACKGROUND: Ninety percent of hip fractures (HF) occur in people older than 64 years. We describe the epidemiological data (age, sex, date of admission and discharge and mortality) of elderly with hip fracture in the different regions of Spain. METHOD: Data obtained from the Minimum Data Set of the Ministry of Health were used to analyse hip fracture incidence (Identified by codes 820.0 through 820.9 of the International Classification of Diseases) from 1996 through 1999. Demographic data of Spanish population were obtained from the National Institute of Statistics. HF rates were calculated using crude and age-and-sex adjusted density of incidence. Factors associated with in-hospital mortality were assessed by multivariate analyses. RESULTS: 89% (130.414) of 146.383 HF cases studied were in elderly patients with a mean age of 82 years old, being 78% females. The results showed a great variability through the different regions. Length of hospital stay was 16 days, and in-hospital mortality was 5%. Global HF rate was 517 cases per 100.000 elderly per year (270 cases/100.000 elderly males and 695/100.000 elderly females). In-hospital mortality was higher in males than females (8.1% vs 4.2%, respectively), increases progressively with age and it is higher during winter months. Factors associated with mortality were old age, male gender, fractured in winter, and living in Regions others than Mediterranean and Canary Islands. CONCLUSIONS: Hip fracture is a condition that occurs more commonly in elderly people. It is more frequent in females and shows a great variation in incidence, mortality and length of hospital stay through different Spanish regions.


Subject(s)
Hip Fractures/epidemiology , Aged , Aged, 80 and over , Female , Humans , Male , Risk Factors , Seasons , Spain/epidemiology
12.
An. med. interna (Madr., 1983) ; 19(8): 389-395, ago. 2002.
Article in Es | IBECS | ID: ibc-12144

ABSTRACT

Fundamento: El 90 por ciento de las fracturas de cadera (FC) ocurren en mayores de 64 años. Pretendemos describir las características epidemiológicas de los ancianos con FC en lo que respecta a edad, sexo, época de ingreso, estancia hospitalaria y mortalidad en las distintas Comunidades Autónomas (CCAA) de España. Método: Se analizan datos de incidencia de FC (Código 820.0 al 820.9 de la Clasificación Internacional de Enfermedades) entre los años 1996 y 1999, obtenidos del registro nacional del Conjunto Mínimo Básico de Datos del Ministerio de Sanidad. Los datos de la población se obtienen del Instituto Nacional de Estadística. Las tasas de FC se calculan mediante densidad de incidencia bruta y ajustada. Se analizan los factores que influyen en la mortalidad hospitalaria mediante análisis multivariante. Resultados: De las 146.383 FC estudiadas 130.414 (89 por ciento) corresponden a mayores de 64 años, con una edad media de 82 años (78 por ciento mujeres). Existe una gran variabilidad en los resultados entre las CCAA. La estancia media hospitalaria es de 16 días y la mortalidad hospitalaria del 5 por ciento. La incidencia global de FC es de 517 casos por 100.000 ancianos y año (270 casos/100.000 varones y 695/100.000 mujeres). La mortalidad hospitalaria es el doble en varones que en mujeres (8,1 por ciento y 4,2 por ciento respectivamente), aumenta exponencialmente con la edad, y es mayor en invierno. Los más ancianos, varones, que se fracturan en invierno y que no habitan en las Comunidades del Mediterráneo y Canarias tienen más probabilidades de fallecer en el hospital tras una FC. Conclusiones: La FC es una patología afecta preferentemente a los ancianos, más frecuentemente en mujeres y con una gran variación en la incidencia, mortalidad y estancia hospitalaria entre las distintas CCAA (AU)


Subject(s)
Aged , Aged, 80 and over , Male , Female , Humans , Risk Factors , Spain , Seasons , Hip Fractures
13.
J Neural Transm (Vienna) ; 108(10): 1135-48, 2001.
Article in English | MEDLINE | ID: mdl-11725816

ABSTRACT

Antioxidant profiles in Parkinson's disease (PD; n = 15), dementias of Alzheimer's type (DAT; 18) and Vascular (VD; 15), and control subjects (C; 14) were studied. Cu-Zn superoxide dismutase (SOD), catalase (CAT), glutathione system (GLU) and thiobarbituric acid reactive substances (TBARS) were measured in erythrocytes; antioxidant capacity (TRAP) in plasma. Biochemical variables were analyzed simultaneously using multi-variate and non-parametric methods. Clinical diagnostic resulted associated with the main source of variability in antioxidant variables (Kruskal-Wallis: H = 32.58, p = 0.000001). Comparison of PD and C resulted highly significant (z = 4.47, p = 0.000047), demonstrating an association between oxidative stress and PD. SOD and TBARS were significantly higher in pathological groups against C (p = 0.0000001, p = 0.051); TRAP resulted lower (p = 0.00015). Discriminant functions constructed using biochemical variables separated pathological groups (93% success) from C, and DAT (88.9%) from VD (73.3%); but not PD from DAT or VD. Antioxidant profiles of PD patients showed characteristics overlapping with DAT (60%) and with VD (40%), suggesting biochemical similarities between them.


Subject(s)
Alzheimer Disease/metabolism , Antioxidants/metabolism , Dementia, Vascular/metabolism , Oxidative Stress , Parkinson Disease/metabolism , Aged , Aged, 80 and over , Analysis of Variance , Discriminant Analysis , Female , Humans , Male , Middle Aged , Statistics, Nonparametric
14.
Clin Chim Acta ; 301(1-2): 87-102, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11020465

ABSTRACT

As oxidative stress in relation with neurological diseases has become an important point in recent research, simple methods to be used in epidemiological studies and clinical practice are required. The hypothesis that the analytical methods used in research laboratories (RLM) can be used interchangeably with commercial kits (CKM) for SOD and TRAP is tested. Both methods were compared using linear transformations of the RLM measurements into the CKM scales. Data were obtained from Alzheimer's, Parkinson's, and vascular dementia patients and controls. The lack of fit and the run's test of residuals were not significant, but the same sign method detected significant nonlinearities (P<0.000001 for SOD, P<0.01 for TRAP). The intragroup CVs of both methods were comparable for TRAP, while in the RLM determinations of SOD resulted in <50% of those obtained with the CKM. The ANCOVA comparison of the regression parameters across the clinical groups resulted significant for SOD (P<0.0001) and not significant for TRAP. Both methods agree in describing the features of the clinical groups, but the degree of agreement at the individual concentration was poor and they could not be readily intercalibrated. Normal and pathological values should be obtained independently for the CKM to insure their applicability to large populations.


Subject(s)
Alzheimer Disease/blood , Antioxidants/metabolism , Dementia, Vascular/blood , Parkinson Disease/blood , Superoxide Dismutase/blood , Alzheimer Disease/enzymology , Case-Control Studies , Dementia, Vascular/enzymology , Humans , Parkinson Disease/enzymology
15.
Rev Neurol ; 31(1): 1-8, 2000.
Article in Spanish | MEDLINE | ID: mdl-10948573

ABSTRACT

INTRODUCTION AND OBJECTIVE: Pyramidal gait impairment (GI) is a classical trait of cerebrovascular disease (CVD). To developed a method to quantify prospectively and transversely GI and disequilibrium, to be applied in the screening of pyramidal and non-pyramidal syndromes associated to different ethiological subtypes of CVD; using an Index of Gait and Equilibrium (IGE). PATIENTS AND METHODS: In constructing IGE, we used 14 equally weighted semiological variables: 6 measure balance, 6 gait, 1 sensitive abnormalities and 1 falls. Two neurologists separately examined each subject in the same day and repeating the evaluation after a week. Data analyses included Kruskal Wallis, chi 2, Spearman correlations and Principal Components. RESULTS: IGE was used in 90 subjects, 43 males, with a mean age of 70.6 years. 3 groups of people were formed: 1. CVD (A, 21 with silent vascular lesions diagnosed by imaging; B, 17 with vascular dementia; C, 21 with stroke); 2. 13 subjects with cautious gait, not associated to any disease; and 3. 18 normal control subjects (age 60-80 years). GI in the non-pyramidal syndrome were significantly related with small vessels disease (chi 2 = 16.37, dof = 1, p < 0.001). CONCLUSIONS: GI in CVD, pyramidal and non-pyramidal syndromes were equally frequent. Increased values of IGE caused by cautious gait in youngest non-stroke patients suggested high probability of silent CVD and significant association with small vessels disease. This preliminary assessment of IGE showed a reproducible and reliable tool for objectification and quantification of gait disorders.


Subject(s)
Cerebral Infarction/complications , Gait , Movement Disorders/etiology , Aged , Aged, 80 and over , Brain/blood supply , Brain/pathology , Cerebral Infarction/diagnosis , Cross-Sectional Studies , Female , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Movement Disorders/diagnosis , Neurologic Examination , Postural Balance , Prospective Studies , Severity of Illness Index
16.
Rev. neurol. (Ed. impr.) ; 31(1): 1-8, 1 jul., 2000.
Article in Es | IBECS | ID: ibc-19843

ABSTRACT

Introducción y objetivos. Las alteraciones de la marcha (AM) de tipo piramidal son clásicamente conocidas en la enfermedad cerebrovascular (ECV). Nuestro objetivo ha sido desarrollar un análisis de las AM piramidales y no piramidales, prospectivo y transversal, cualitativo y cuantitativo, vinculado con los diferentes subtipos de la ECV, utilizando una escala de marcha y equilibrio (EME).Pacientes y métodos. Para conformar la EME se utilizaron 14 variables semiológicas, 6 de postura y equilibrio, 6 de marcha, 1 de trastornos sensitivos y 1 de caídas. Dos neurólogos examinaron separadamente a cada persona, y repitieron las determinaciones a la semana siguiente. Los datos fueron evaluados con el test de Kruskal Wallis, coeficiente de Spearman, test de la ji al cuadrado y componentes principales. Resultados. Noventa sujetos, con una edad media de 70,6 años, conformaron tres grupos: 1. ECV: 21 con lesiones vasculares silentes en neuroimagen, 17 con demencia vascular probable y 21 con ataque clínico vascular cerebral agudo; 2. Trece con marcha cautelosa sin enfermedad evidente; 3. Dieciocho controles normales de 60 a 80 años. Las AM con síndrome no piramidal se relacionaron significativamente con la enfermedad de las pequeñas arterias ( c2= 16,37, gdl= 1, p< 0,0001). Conclusiones. En la ECV, las AM no piramidales fueron tan frecuentes como las piramidales. Un valor aumentado de EME provocado por una marcha cautelosa, en pacientes más jóvenes, sugirió una alta probabilidad de ECV silente y una significativa asociación con las lesiones de pequeña arteria. Estos resultados preliminares sugieren que la EME es un instrumento útil para objetivar y cuantificar las AM (AU)


Subject(s)
Middle Aged , Aged , Aged, 80 and over , Male , Female , Humans , Gait , Neuropsychological Tests , Movement Disorders , Memory , Neurologic Examination , Prospective Studies , Amnesia, Anterograde , Cerebral Infarction , Cognition Disorders , Cross-Sectional Studies , Alzheimer Disease , Magnetic Resonance Imaging , Postural Balance , Severity of Illness Index , Telencephalon
17.
Age Ageing ; 28(2): 221-7, 1999 Mar.
Article in English | MEDLINE | ID: mdl-10350423

ABSTRACT

INTRODUCTION: the antigen CD28, expressed in most T cells, has co-stimulatory properties and plays a pivotal role in clonal T cell anergy mechanisms. METHODS: we have compared proliferative T cell responses after anti-CD3 or in phorbol myristate acetate activation with concomitant CD28 signal in peripheral blood mononuclear cells from healthy donors aged over 65 [elderly donors; ED] and young healthy donors (YD); mean age 30+/-2.7 years). RESULTS: no proliferative responses were observed in ED and YD with anti-CD28 monoclonal antibody alone. These responses both were defective in ED, particularly after anti-CD3 monoclonal antibody stimulus (7604 compared with 12,438 c.p.m. in YD, P=0.001) and were corrected when anti-CD28 monoclonal antibody was added to the culture (17,216 vs 18,536, not significant). Functional integrity of the CD28 co-stimulatory pathway was demonstrated by analysis of CD25 expression, interleukin-2 secretion and interleukin-2 gene expression on T cells from ED and YD. Age-associated phenotypic T cell changes were not crucial for an adequate CD28 response. CONCLUSION: these experiments demonstrate the integrity of the CD28 pathway in elderly people, and suggest that ageing does not affect different T cell activation pathways equally.


Subject(s)
CD28 Antigens/metabolism , Signal Transduction , T-Lymphocytes/metabolism , Adult , Aged , Aging/immunology , Cell Division , Female , Humans , Immunophenotyping , Interleukin-2/genetics , Interleukin-2/metabolism , Male , Mitogens/pharmacology , Receptors, Interleukin-2/biosynthesis , T-Lymphocytes/cytology , T-Lymphocytes/drug effects , Tetradecanoylphorbol Acetate/pharmacology , Transcription, Genetic
18.
Exp Gerontol ; 34(2): 217-29, 1999 Apr.
Article in English | MEDLINE | ID: mdl-10363788

ABSTRACT

Immunosenescence is characterized by an increase in autoantibody production. Because both T and B cell stimulation are key events for producing antibodies, we investigated early T and B cell activation by means of CD23 and CD40L (two very early activation antigens). PBMC from elderly humans (EH) were studied following culture with either medium, anti-CD3mAb, rIL-4, or PMA + ionomycin. CD23 expression on elderly B cells after anti-CD3 challenge of PBMC, a reflect of T-dependent B cell activation, was clearly defective. Conversely, CD23 expression on EH B cells following activation with soluble factors as rIL-4 was preserved. CD40L expression was also impaired in EH T cells following anti-CD3 challenge. However, activation by means of PMA and/or ionomycin was preserved both in T cells (CD40L expression) and in B cells (CD23 expression). These results indicate that a defective T-dependent B cell activation related to defective T cell activation located between surface membrane and PKC/ionomycin function is an intrinsic characteristic of immunosenescence. We have not found intrinsic B-cell defects, and we conclude that the characteristically impaired early B cell activation in EH is mostly due to T cell defects.


Subject(s)
Aging/immunology , B-Lymphocytes/immunology , Lymphocyte Activation , T-Lymphocytes/immunology , Adult , Aged , Aged, 80 and over , Antibodies, Monoclonal/pharmacology , B-Lymphocytes/drug effects , CD3 Complex/metabolism , CD40 Ligand , Female , Humans , In Vitro Techniques , Interleukin-4/pharmacology , Lymphocyte Cooperation , Male , Membrane Glycoproteins/metabolism , Receptors, IgE/metabolism , T-Lymphocytes/drug effects , Tetradecanoylphorbol Acetate/pharmacology
19.
Int J Food Microbiol ; 46(1): 9-26, 1999 Jan 12.
Article in English | MEDLINE | ID: mdl-10050681

ABSTRACT

The implementation of a risk analysis program as risk assessment and critical control points (RACCP) is most necessary in order to accomplish the foodborne industries current objective of total quality. The novelty of this technique, when compared to actual hazard analysis and critical control points (HACCP) and its extension to incorporate elements of quantitative risk analysis (QRA), is that RACCP considers the risk of the consequences produced by the production process performance deviations, both inside and outside the company, and also identifies their causative factors. On the other hand, the techniques to be taken in order to prevent or mitigate the consequences of such deviations must be consistent with the former data, but the need for a cost-benefit assessment must not be ignored so that the chosen technique be most profitable for the company. An example developed in a mineral water bottling plant showed that RACCP application is feasible and useful. During this example case, RACCP demonstrated it could obtain a profitable production process that keeps quality and safety of the final product at its maximum, while providing protection to both company and consumer.


Subject(s)
Food Microbiology , Food-Processing Industry , Risk Assessment , Water Microbiology , Cost-Benefit Analysis , Food-Processing Industry/economics , Quality Control , Risk Assessment/economics , Risk Management , Water Purification
20.
Age Ageing ; 25(6): 470-8, 1996 Nov.
Article in English | MEDLINE | ID: mdl-9003885

ABSTRACT

This study characterizes the early steps of T lymphocyte activation in elderly subjects. The expression of CD69, the earliest inducible antigen which appears with T lymphocyte activation, was assessed in T cells cultured with medium, anti-CD3 or PMA. The proliferative responses of T cells stimulated through CD69 and CD3 pathways were also studied. Donors included 31 healthy elderly [age mean (SD) 80(8) years] and 33 healthy young [age 30(5) years] subjects. In elderly people, the expression of CD69 was lower in T cells cultured with medium [3.4% (1.65-5.9; 25-75 percentiles) vs. 10% (6-18), p < 0.0003] and anti-CD3 activated [28.1% (16.5-53.8) vs. 79.5% (73-89), p < 0.0002] T cells. With PMA at 10 ng/ml, CD69 expression was higher in both groups of T cells, though still lower in the aged [84.5% (70.9-94.9) vs. 99% (65.7-100), p = 0.051]. CD69 T cells expression was equal in both groups with 2 ng/ml of PMA, but the co-stimulatory responses to CD69 under these conditions and in the presence of anti-CD3 were lower in the aged (16914 vs. 28904 cpm, p < 0.02) and (6944 vs. 14370 cpm, p < 0.02) respectively. Aged T cells failed to express CD25 at the same levels of young T cells when stimulated with CD69. These results suggests an age-associated defect in the very early steps of T lymphocyte activation that might influence later stages of lymphocyte function. An alteration in the transmission of the activation signal from the cell surface to protein kinase C may play a primary role in this defect.


Subject(s)
Aging/immunology , Lymphocyte Activation/immunology , T-Lymphocytes/immunology , Aged , Aged, 80 and over , Antigens, CD/blood , Antigens, Differentiation, T-Lymphocyte/blood , Female , Humans , Immune Tolerance/immunology , Lectins, C-Type , Male , Reference Values
SELECTION OF CITATIONS
SEARCH DETAIL
...